World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
129
Citations
117801
World Ranking
237
National Ranking
155

Medicine

D-Index
129
Citations
118168
World Ranking
2518
National Ranking
1418

Robert D. Schreiber publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert D. Schreiber sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 258 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert D. Schreiber D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert D. Schreiber sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 129 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2019 - Distinguished Fellows of the American Association of Immunologists (AAI)
  • 2013 - Member of the National Academy of Sciences
  • 2010 - Fellow of the American Academy of Arts and Sciences
  • 1996 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Robert D. Schreiber is affiliated with Washington University in St. Louis in the United States. Their research spans multiple fields with a focus on medicine and immunology and microbiology. Subfields of particular interest include immunology, oncology, molecular biology, pathology and forensic medicine, and radiology, nuclear medicine and imaging.

The main topics addressed in their research involve immunotherapy and immune responses, cancer immunotherapy and biomarkers, CAR-T cell therapy research, immune cell function and interaction, monoclonal and polyclonal antibodies research, cancer genomics and diagnostics, and genetic factors in colorectal cancer.

Notable recent papers by Robert D. Schreiber include:

  • TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020, Cell)
  • cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity (2020, Nature)
  • Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction (2020, Cell)
  • Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads (2021, Proceedings of the National Academy of Sciences)
  • BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4+ T cell responses to persistent antigen (2022, Immunity)

Frequent co-authors include Elaine R. Mardis, Philip D. Greenberg, Kenneth M. Murphy, Jasreet Hundal, and Hussein Sultan.

The scientist has published numerous times in venues such as Cancer Immunology Research, Regular and Young Investigator Award Abstracts, arXiv (Cornell University), bioRxiv (Cold Spring Harbor Laboratory), and the Journal of Clinical Oncology.

Throughout their career, Robert D. Schreiber has received several awards, including:

  • Distinguished Fellows of the American Association of Immunologists (AAI), 2019
  • Member of the National Academy of Sciences, 2013
  • Fellow of the American Academy of Arts and Sciences, 2010
  • Fellow of the American Association for the Advancement of Science (AAAS), 1996

Best Publications

  • Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

    Robert D. Schreiber;Lloyd J. Old;Mark J. Smyth;Mark J. Smyth

  • Cancer immunoediting: from immunosurveillance to tumor escape.

    Gavin P. Dunn;Allen T. Bruce;Hiroaki Ikeda;Lloyd J. Old

  • How cells respond to interferons

    George R. Stark;Ian M. Kerr;Bryan R. G. Williams;Robert H. Silverman

  • Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

    David Hockenbery;Gabriel Nuñez;Curt Milliman;Robert D. Schreiber

  • Neoantigens in cancer immunotherapy

    Ton N. Schumacher;Robert D. Schreiber

  • IFNγ, and lymphocytes prevent primary tumour development and shape tumour immunogenicity

    Vijay Shankaran;Hiroaki Ikeda;Allen T. Bruce;J. Michael White

  • The three Es of cancer immunoediting.

    Gavin P. Dunn;Lloyd J. Old;Robert D. Schreiber

  • The immunobiology of cancer immunosurveillance and immunoediting

    Gavin P. Dunn;Lloyd J. Old;Robert D. Schreiber

  • Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

    Chih Hao Chang;Jing Qiu;David O'Sullivan;Michael D. Buck

  • Natural Innate and Adaptive Immunity to Cancer

    Matthew D. Vesely;Michael H. Kershaw;Michael H. Kershaw;Michael H. Kershaw;Robert D. Schreiber;Mark J. Smyth;Mark J. Smyth

  • Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity

    Kai Hildner;Brian T. Edelson;Whitney E. Purtha;Mark Diamond

  • Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

    Matthew M. Gubin;Xiuli Zhang;Heiko Schuster;Etienne Caron

  • Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway

    Marco A Meraz;Marco A Meraz;J.Michael White;Kathleen C.F Sheehan;Erika A Bach

  • Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice

    Daniel H. Kaplan;Vijay Shankaran;Anand S. Dighe;Elisabeth Stockert

  • Interferons, immunity and cancer immunoediting.

    Gavin P. Dunn;Catherine M. Koebel;Robert D. Schreiber

  • The Molecular Cell Biology of Interferon-gamma and its Receptor

    Michael A. Farrar;Robert D. Schreiber

  • New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escape

    Deepak Mittal;Matthew M Gubin;Robert D Schreiber;Mark J Smyth;Mark J Smyth

  • Adaptive immunity maintains occult cancer in an equilibrium state

    Catherine M. Koebel;William Vermi;William Vermi;Jeremy B. Swann;Jeremy B. Swann;Nadeen Zerafa

  • Cytokine signaling in 2002: new surprises in the Jak/Stat pathway.

    John J O'Shea;Massimo Gadina;Robert D Schreiber

  • THE IFN-GAMMA RECEPTOR: A PARADIGM FOR CYTOKINE RECEPTOR SIGNALING

    Erika A. Bach;Michel Aguet;Robert D. Schreiber

Frequent Co-Authors

Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Lloyd J. Old
Lloyd J. Old Ludwig Cancer Research
Jean-Laurent Casanova
Jean-Laurent Casanova The University of Texas Southwestern Medical Center
William Vermi
William Vermi University of Brescia
Kenneth M. Murphy
Kenneth M. Murphy Washington University in St. Louis
Emil R. Unanue
Emil R. Unanue Washington University in St. Louis
Elaine R. Mardis
Elaine R. Mardis The Ohio State University
Emmanuelle Jouanguy
Emmanuelle Jouanguy Necker-Enfants Malades Hospital
Marco Colonna
Marco Colonna Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise in Immunology, pursuing related online degrees can open diverse career opportunities. Many professionals start by exploring the best online BSN programs for non nurses to build a strong foundation in nursing and healthcare. These programs offer accessible pathways for individuals beginning their nursing careers without prior experience.

After completing initial nursing credentials, accelerated options like the accelerated FNP programs allow students to fast-track their specialization as family nurse practitioners, blending advanced patient care with immunological knowledge. For nurses aiming to shift focus, obtaining an FNP to acute care certification enhances their ability to manage critically ill patients, integrating immunology with acute care practice.

Finding the right program is essential, and for many, options like accelerated nursing programs near me offer flexible, attainable routes to advance. Together, these related degrees and certifications empower immunology-focused professionals to impact patient outcomes and broaden their healthcare careers.

Best Scientists Citing Robert D. Schreiber

Trending Scientists